MARKET

CLVLF

CLVLF

Clinuvel Pharma
OTCPK
6.60
NaN%
Closed 09:30 05/22 EDT
OPEN
--
PREV CLOSE
6.60
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
8.34
52 WEEK LOW
6.60
MARKET CAP
332.82M
P/E (TTM)
15.36
1D
5D
1M
3M
1Y
5Y
1D
Clinuvel Issues 887,956 Unquoted Performance Rights Under Incentive Scheme
TipRanks · 05/07 01:57
Clinuvel advances Nasdaq Level II ADR plans amid ongoing SEC review
TipRanks · 04/27 23:46
FDA Drops QT Study Requirement for Clinuvel’s SCENESSE
TipRanks · 04/26 23:13
Clinuvel Pharmaceuticals (CLVLF) Gets a Buy from Jefferies
TipRanks · 04/26 12:18
Clinuvel Secures EMA Guidance for Pivotal Vitiligo Trial of SCENESSE
TipRanks · 04/23 23:14
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
Barchart · 04/15 01:18
Clinuvel Issues New Shares, Confirms Compliance With Disclosure Rules
TipRanks · 04/12 23:21
Clinuvel Leverages AAD 2026 to Advance Vitiligo, EPP Strategy and U.S. Profile
TipRanks · 04/02 01:29
More
About CLVLF
Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Webull offers Clinuvel Pharmaceuticals Ltd stock information, including OTCPK: CLVLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLVLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLVLF stock methods without spending real money on the virtual paper trading platform.